Back to results
US 7,008,943 B2Granted
1-(Pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
AssigneePharmacia & Upjohn Company
InventorsMalcolm Wilson Moon, Walter Morozowich, Ping Gao
Life of this patent
Estimating the term…
Abstract
The present invention is directed to 1-pyrrolidin-1-ylmethyl-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives that modulate the activity of protein kinases (“PKs”). Pharmaceutical compositions comprising these compounds, methods of treating diseases related to abnormal PK activity utilizing pharmaceutical compositions comprising these compounds and methods of preparing them are also disclosed.
Claims8
A compound of the Formula (I):
- wherein:
- R3, R5 and R6 are independently selected from the group consisting of hydrogen, alkyl, trihaloalkyl, cycloalkyl, alkenyl, alkynyl, aryl, hydroxy, alkoxy, aryloxy, mercapto, alkylthio, arylthio, sulfinyl, sulfonyl, S-sulfonamido, N-sulfonamido, trihalomethane-sulfonamido, carbonyl, C-carboxy, O-carboxy, C-amido, N-amido, cyano, nitro, halo, O-carbamyl, N-carbamyl, O-thiocarbamyl, N-thiocarbamyl, amino and —NR11R12, where R11 and R12 are independently selected from the group consisting of hydrogen, alkyl, cycloalkyl, aryl, carbonyl, acetyl, sulfonyl, trifluoromethanesulfonyl and, together with the nitrogen to which they are attached, form a five- or six-member heteroalicyclic ring;
- R7 is hydrogen;
- R4 is halo;
- R8 and R10 are independently unsubstituted lower alkyl;
- and
- R9 is lower alkyl substituted with C-carboxy, or —C(═O)NHR13 wherein R13 is lower alkyl substituted with amino or heteroalicyclic and optionally substituted with hydroxyl.
4 more elements
Dependencies are inferred from the claim text.